Evidence map›Paper›PMID 39992439›Full record

ArticleVirchows Archiv : an international journal of pathology2025

Can we improve the diagnosis of invasion in encapsulated follicular-patterned thyroid tumors? Data from a massive international e-learning initiative.

Yara Mansour, Léonor Chaltiel, Ana Cavillon, Abderrahmane Al Bouzidi, Bakarou Kamate, Antonio De Leo, Andriamampihantona Lalaoarifetra Ramiandrasoa, Karima Mrad, Nassim Vibert, Manuel Sobrinho-Simoes and 3 more

Abstract read
In one paragraph

Article in Virchows Archiv : an international journal of pathology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Yara MansourDepartment of Pathology, Haut-Leveque Hospital, University Medical Centre, Bordeaux, France.
Léonor ChaltielBiostatistics Unit, Institut Claudius Régaud, Institut Universitaire du Cancer de Toulouse - Oncopole Toulouse, Toulouse, France.
Ana CavillonBiostatistics Unit, Institut Claudius Régaud, Institut Universitaire du Cancer de Toulouse - Oncopole Toulouse, Toulouse, France.
Abderrahmane Al BouzidiDepartment of Pathology Cheikh, Faculty of Medicine, Khalifa International Hospital, University Mohammed VI of Health Sciences, Casablanca, Morocco.
Bakarou KamateFaculty of Medicine and Odontostomatology, University of Sciences Techniques and Technologies of Bamako, Bamako, Mali.
Antonio De LeoAnatomic Pathology, Department of Medical and Surgical Sciences (DIMEC), University of Bologna Medical Center, Bldg. 20 - Policlinico S.Orsola, Room 020+4A 004, Via Massarenti 9, Bologna, 40138, Italy.
Andriamampihantona Lalaoarifetra RamiandrasoaAnatomic Pathology, Malagasy Lutheran Health Department (SALFA), Antananarivo, Madagascar.
Karima MradPathology Department, Faculty of Medicine, Salah Azaiez Institute, El Manar University, Tunis, Tunisia.
Nassim VibertRadiotherapy Department, Bergonié Institute, Bordeaux, France.
Manuel Sobrinho-Simoes *Department of Pathology, Institute of Molecular Pathology and Immunology (IPATIMUP), University of Porto, Porto, Portugal.
Giovanni Tallini *Anatomic Pathology, Department of Medical and Surgical Sciences (DIMEC), University of Bologna Medical Center, Bldg. 20 - Policlinico S.Orsola, Room 020+4A 004, Via Massarenti 9, Bologna, 40138, Italy. giovanni.tallini@unibo.it.ORCID http://orcid.org/0000-0003-0113-6682
Philippe Vielh *Medipath and American Hospital of Paris, Paris, France.
Geneviève Belleannée *Department of Pathology, Haut-Leveque Hospital, University Medical Centre, Bordeaux, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With the reclassification of non-invasive follicular variant of papillary thyroid carcinoma as "tumors" (NIFTP), the challenge of diagnosing carcinoma lies in recognizing invasion: blood vessel invasion (BVI) or capsular invasion (CI). We aimed to assess reproducibility in diagnosing BVI and CI in follicular-patterned tumors using a web-platform, under conditions as close as possible to routine surgical pathology practice. Six-hundred-fourteen pathologists reviewed 69 thyroid lesions diagnostically challenging for BVI or CI, made available in three rounds: before, immediately after, and three months after a training lecture given by an expert pathologist. Each lesion was associated with a quiz (five queries: certain CI, doubtful CI, certain BVI, doubtful BVI, or no invasion). Intraobserver agreement was fair for five queries and moderate for two categories (i.e., BVI vs. the other four queries). Interobserver overall agreement (OA) of participants was fair for all five queries and moderate for two categories (OA for five queries: 0 at each round; OA [95% CI] for two categories: Round 1 to 3: 8.7 [3.3-18.0], 2.9 [0.4-10.1], 4.3 [0.9-12.2]). Importantly, participants agreement with expert consensus improved following the training lecture and was maintained for three months (OA for five queries: Round 1 to 3: 40.6 [13.0-62.3], 49.3 [21.7-69.6], 49.3 [21.7-78.3]; OA for two categories: Round 1 to 3: 72.5 [60.9-89.9], 76.8 [62.3-88.4], 75.4 [60.9-89.9]). This study reveals the difficulty of applying clearly defined BVI and CI criteria to routine practice, but a specifically designed training lecture improves diagnostic accuracy, and the improvement is retained over months.

Indexed as

Adenocarcinoma, FollicularThyroid NeoplasmsFemaleHumansMaleNeoplasm InvasivenessObserver VariationReproducibility of ResultsThyroid Cancer, PapillaryCapsular invasionE-learningFollicular patternThyroid tumorsVascular invasion

Identifiers

PMID39992439
PMCPMC12289735

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.